Artificial IntelligenceNCT05368636
Combining Tongue and Gastric Cancer Cascade With Artificial Intelligence
An observational study of Artificial Intelligence and Tongue, run by Shandong University at 1 site in China.
Trial summary
This study combines artificial intelligence with tongue images, by collating and collecting tongue images and diagnostic and pathological results of gastroscopic diseases, mining and analysing the correlation between tongue images and OLGA, OLGIM stages, Correa sequences and constructing prediction models, to deeply… Read more about this study
- Who is it for?
- Ages 40 to 80 yearsHealthy volunteers can take part
- Conditions the study is for
- Artificial Intelligence, Tongue, Gastric Cancer
- How many people
- 4,000 participants
- Where
- 1 siteChina
- Study dates
- 30 Jun 2022to 30 Jun 2025
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 40 to 80 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Patients aged 40-80 years who will undergo gastroscopy and fulfil the inclusion criteria who do not meet the exclusion criteria.
Who may be able to join
- Patients between 40 and 80 years of age who are scheduled for gastroscopy.
- Patients all gave their informed consent and signed the informed consent form.
Who cannot join
- Persons with severe cardiac, cerebral, pulmonary or renal dysfunction or psychiatric disorders who are unable to participate in gastroscopy.
- Patients with previous surgical procedures on the gastrointestinal tract.
- Patients taking bismuth or other staining drugs.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Analyzing the Link Between Tongue Images and Gastric Cancer Cascade Response Using Artificial Intelligence Techniques
This study combines artificial intelligence with tongue images, by collating and collecting tongue images and diagnostic and pathological results of gastroscopic diseases, mining and analysing the correlation between tongue images and OLGA, OLGIM stages, Correa sequences and constructing prediction models, to deeply investigate the relationship between tongue images and precancerous diseases, precancerous lesions and gastric cancer.
Read the detailed description
Firstly, tongue pictures and patient information will be collected after the patient signed an informed consent form.
Secondly, after the patient undergoes gastroscopy, patient gastroscopy reports and pathology reports will be obtained.
Thirdly, the investigator will assess the patient's gastroscopy report for the Correa sequence of gastric cancer with OLGA and OLGIM staging.
Finally, the patient's tongue image, information and gastric cancer cascade response are matched to construct an artificial intelligence model and assess the quality of the model.
- Conditions
- Artificial Intelligence, Tongue, Gastric Cancer
- Keywords
- Artificial Intelligence, tongue, gastric cancer
- Medical subject headings
- Stomach Neoplasms
What is being measured
The primary outcome is the main question the study is designed to answer.
Sensitivity
Sensitivity of artificial intelligence models Sensitivity = number of true positives / (number of true positives + number of false negatives) * 100%.
Measured: 3 years
Specificity
Specificity of Artificial Intelligence Models Specificity = number of true negatives / (number of true negatives + number of false positives))*100%
Measured: 3 years
Positive predictive values(PPV)
Positive predictive values from artificial intelligence models Positive predictive value = true positive / (true positive + false positive)*100%
Measured: 3 years
Negative predictive values(NPV)
Negative predictive values for artificial intelligence models Negative predictive value = true negative / (true negative + false negative)*100%
Measured: 3 years
AUC (95% CI)
area under the receiver operating characteristic curve (AUC)
Measured: 3 years
Accuracy
Accuracy of artificial intelligence models Accuracy = (true positives + true negatives) / total number of subjects * 100%
Measured: 3 years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted10 May 2022
- Study start30 Jun 2022 (estimated)
- Primary completion30 Jun 2024 (estimated)
- Study completion30 Jun 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Artificial IntelligenceStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 4,000 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Shandong University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Xiuli Zuo, Shandong University
- Investigators
- Xiuli Zuo, MD,PhD, Principal investigator, Qilu Hospital of Shandong University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05368636
- Sponsor's protocol ID
- 2022SDU-QILU-G001
- Status last verified
- Jun 2022
- First submitted
- 5 May 2022
- Last updated
- 22 Jun 2022
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 22 Jun 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Analyzing the Link Between Tongue Images and Gastric Cancer Cascade Response Using Artificial Intelligence Techniques
- ClinicalTrials.gov ID
- NCT05368636
- Acronym / sponsor ID
- 2022SDU-QILU-G001
- Conditions
- Artificial Intelligence, Tongue, Gastric Cancer
- Keywords
- Artificial Intelligence, tongue, gastric cancer
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 4,000 participants (estimated)
- Lead sponsor
- Shandong UniversityUniversity, hospital or other
- Study start
- 30 Jun 2022 (estimated)
- Primary completion
- 30 Jun 2024 (estimated)
- Study completion
- 30 Jun 2025 (estimated)
- First posted
- 10 May 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study combines artificial intelligence with tongue images, by collating and collecting tongue images and diagnostic and pathological results of gastroscopic diseases, mining and analysing the correlation between tongue images and OLGA, OLGIM stages, Correa sequences and constructing prediction models, to deeply investigate the relationship between tongue images and precancerous diseases, precancerous lesions and gastric cancer.
Detailed description
Firstly, tongue pictures and patient information will be collected after the patient signed an informed consent form.
Secondly, after the patient undergoes gastroscopy, patient gastroscopy reports and pathology reports will be obtained.
Thirdly, the investigator will assess the patient's gastroscopy report for the Correa sequence of gastric cancer with OLGA and OLGIM staging.
Finally, the patient's tongue image, information and gastric cancer cascade response are matched to construct an artificial intelligence model and assess the quality of the model.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 40 to 80 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Patients aged 40-80 years who will undergo gastroscopy and fulfil the inclusion criteria who do not meet the exclusion criteria.
Key inclusion criteria (2 listed)
- Patients between 40 and 80 years of age who are scheduled for gastroscopy.
- Patients all gave their informed consent and signed the informed consent form.
Key exclusion criteria (3 listed)
- Persons with severe cardiac, cerebral, pulmonary or renal dysfunction or psychiatric disorders who are unable to participate in gastroscopy.
- Patients with previous surgical procedures on the gastrointestinal tract.
- Patients taking bismuth or other staining drugs.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Sensitivity
Time frame: 3 years
Sensitivity of artificial intelligence models Sensitivity = number of true positives / (number of true positives + number of false negatives) * 100%.
Specificity
Time frame: 3 years
Specificity of Artificial Intelligence Models Specificity = number of true negatives / (number of true negatives + number of false positives))*100%
Positive predictive values(PPV)
Time frame: 3 years
Positive predictive values from artificial intelligence models Positive predictive value = true positive / (true positive + false positive)*100%
Negative predictive values(NPV)
Time frame: 3 years
Negative predictive values for artificial intelligence models Negative predictive value = true negative / (true negative + false negative)*100%
AUC (95% CI)
Time frame: 3 years
area under the receiver operating characteristic curve (AUC)
Accuracy
Time frame: 3 years
Accuracy of artificial intelligence models Accuracy = (true positives + true negatives) / total number of subjects * 100%
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 22 Jun 2022.
Related trials for Artificial Intelligence
RecruitingObservational study
AI-powered ECG Analysis Using Willem™ Software in High-risk Cardiac Patients (WILLEM)
Cardiomyopathies, Cardiac Arrest
Recruiting
Managing Premyopia in Chinese Children Using Artificial Intelligence Assisted Defocus Incorporated Multiple Segments Based Spectacle Lens: a Randomized Controlled Clinical Trial
Pre-myopia, Myopia
Not yet recruitingObservational study
AI-assisted Tracheal Intubation in Children
Intubation
Recruiting
AI-assisted Home-based Intervention for ADHD Children
ADHD - Attention Deficit Disorder With Hyperactivity, ADHD - Combined Type
Not yet recruitingObservational study
Discovering Determinants of Food Intake by Application of Artificial Intelligence to Complex, High-Dimensional Data
Healthy Volunteer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Xiuli Zuo, MD,PhD principal investigator
Qilu Hospital of Shandong University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Artificial Intelligence and Tongue, run by Shandong University at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 22 Jun 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Xiuli Zuo, MD, PhD (86 15588818685 ext. 0531-88369277, zuoxiuli@sdu.edu.cn), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Sensitivity (time frame: 3 years). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Jun 2022.